Kadmon Holdings, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|---|
| Revenue | $8.3M | $5.1M | $1.4M | $5.6M | $26.1M | $35.7M |
| Operating income | −$102.3M | −$89.1M | −$85.9M | −$13.9M | −$115.4M | −$139.9M |
| Net income | −$108.9M | −$61.4M | −$54.3M | −$17.6M | −$208.8M | −$147.1M |
| Total assets | $162.7M | $214.8M | $144.7M | $83.6M | $62.6M | $84.1M |
| Total liabilities | $46.7M | $49.1M | $56.3M | $81.8M | $87.7M | $296.2M |
| Equity | $116.0M | $165.7M | $88.4M | $1.8M | −$25.2M | −$270.9M |
| EPS (diluted) | — | — | $-0.27 | $-0.39 | — | — |
| Shares out. | 159.8M | 126.9M | 78.7M | 51.8M | 45.1M | 0 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2020- Operating margin
- −1234.1%
- Net margin
- −1314.1%
- Return on equity
- −93.9%
- Return on assets
- −66.9%
- Return on capital (ROCE)
- −76.8%
- Liabilities / assets
- 28.7%
- Debt / equity
- 0.40×
- Book value / share
- $0.73
- Revenue growth (YoY)
- 62.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2020- Altman Z″ (distress)
- -6.17distress
- Accruals / assets
- −13.1%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Waksal HarlanOfficer — President, CEO | Nov 9, 2021 | D | 177,945 | $9.50 |
| Flowers Cynthia LouiseDirector | Nov 8, 2021 | Gift | 20,150 | $0.00 |
| Kirsch Arthur SDirector | Nov 9, 2021 | D | 30,000 | $9.50 |
| Moss Gregory S.Officer — EVP, Gen. Coun. / CCO. | Nov 9, 2021 | D | 17,671 | $9.50 |
| Meehan StevenOfficer — EVP, Chief Financial Officer | Nov 9, 2021 | D | 24,909 | $9.50 |
| Carver KyleOfficer — SVP, CAO, Controller | Nov 9, 2021 | D | 15,420 | $9.50 |
| Bauer EugeneDirector | Nov 9, 2021 | D | 1,716 | $9.50 |
| Kirsch Arthur SDirector | May 13, 2021 | Grant | 20,000 | $3.58 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · Debt acceleration / triggering event · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 9, 2021
- Shareholder voteNov 5, 2021
- Results of operationsNov 4, 2021
- Other material eventOct 28, 2021
- Other material eventOct 21, 2021
- Entered a material agreement · Director / officer change · Other material eventSep 8, 2021
- Results of operationsAug 5, 2021
- Other material eventJul 19, 2021
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ASCHEDULE 13G (AMENDMENT NO. 1)Feb 14, 2022
- 15-12BNov 19, 2021
- EFFECTNov 15, 2021
- EFFECTNov 15, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
- 4OWNERSHIP DOCUMENTNov 9, 2021
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.